SPOTLIGHT -
40 Years of Psychiatric Times
FDA Grants Fast Track Designation to Posdinemab for Early Alzheimer Disease
LB-102 for Schizophrenia Sees Positive Phase 2 Topline Results
School Shooters: Troubled Teens or Cold-Blooded Killers?